A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED)

Clinical trial NCT00539721 · COMPLETED

Trial details

NCT number: NCT00539721
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postoperative Nausea and Vomiting

Start date: 2007-10-01
Primary completion: 2008-07-01
Enrollment: 619

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.